INT275502

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.09
First Reported 2009
Last Reported 2009
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0
Pain Relevance 0.04

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

transport (Slc17a5) extracellular space (Ccl4) extracellular region (Ccl4)
cytoplasmic membrane-bounded vesicle (Slc17a5) plasma membrane (Slc17a5) transmembrane transport (Slc17a5)
Anatomy Link Frequency
body 1
Ccl4 (Mus musculus)
Slc17a5 (Mus musculus)
Pain Link Frequency Relevance Heat
Potency 1 81.44 Quite High
Paracetamol 5 5.00 Very Low Very Low Very Low
cytokine 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Injury 7 41.76 Quite Low
Diabetes Mellitus 9 5.00 Very Low Very Low Very Low
Contagious Ecthyma 2 5.00 Very Low Very Low Very Low
Sprains And Strains 1 5.00 Very Low Very Low Very Low
Body Weight 1 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Forty-eight hours after administration of CCl4 (20 ml/kg body wt), the serum levels of AST and ALT were significantly elevated, from 60.88 ± 10.11 to 164.49 ± 27.16, while the ALT levels were elevated from 31.17 ± 10.53 to 111.4 ± 65.05. rAPSL administrated by the intraperitoneal route (3.0 mg/kg body wt and 1.0 mg/kg body wt) can markedly weaken the higher levels of serum AST and ALT induced by CCl4 (Table 2).
CCl4 Positive_regulation (induced) of serum AST in body
1) Confidence 0.09 Published 2009 Journal Marine Drugs Section Body Doc Link PMC2707046 Disease Relevance 0 Pain Relevance 0.04

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox